CASI Pharmaceuticals
CASI
#10181
Rank
HK$0.14 B
Marketcap
HK$7.13
Share price
8.63%
Change (1 day)
-73.26%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): -HK$20.46

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$20.39. In 2024 the company made an earnings per share (EPS) of -HK$19.92 a decrease over its 2023 EPS that were of -HK$15.72.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$20.462.68%
2024-HK$19.9226.73%
2023-HK$15.72-32.89%
2022-HK$23.4211.9%
2021-HK$20.93-38.44%
2020-HK$34.00-8.96%
2019-HK$37.3550%
2018-HK$24.9077.78%
2017-HK$14.015.88%
2016-HK$13.23-22.73%
2015-HK$17.12-76.09%
2014-HK$71.59318.18%
2013-HK$17.12-71.79%
2012-HK$60.6965.96%
2011-HK$36.57-50%
2010-HK$73.15-18.97%
2009-HK$90.26-63.64%
2008-HK$248.233.57%
2007-HK$239.67-60.56%
2006-HK$607.7397.22%
2005-HK$308.14-2.7%
2004-HK$316.70-45.59%
2003-HK$582.05-61.8%
2002-HK$1,524-25.52%
2001-HK$2,046-21.38%
2000-HK$2,60213.86%
1999-HK$2,285149.53%
1998-HK$915.8798.15%
1997-HK$462.2210.2%
1996-HK$419.42